tech:

taffy

Silicon Valley Heavyweights Start $3M Breakthrough Prize

[Techtaffy Newsdesk]

Silicon Valley heavyweights Art Levinson (chairman of the board at Apple, and chairman and former CEO of Genentech), Sergey Brin (co-founder, Google), Anne Wojcicki (co-founder of 23andMe, and wife of Mr. Brin) , Mark Zuckerberg (founder chairman, and CEO of Facebook), Priscilla Chan (wife of Mr. Zuckerberg) and Yuri Milner (founder of Digital Sky Technologies) have come together to start  the Breakthrough Prize in Life Sciences.

There will be five annual prizes of $3 million each. (The Nobel Prize amounts for 2012 is $1.2 million, in case you were wondering). Beyond the five years, the founding sponsors may continue their awards, and there may be others joining in, as well.

Sergey Brin: Curing a disease should be worth more than a touchdown.  

Art Levinson, will serve as the chairman of the board at the Breakthrough Foundation. Additional directors will include Anne Wojcicki , Mark Zuckerberg and Yuri Milner.

The Breakthrough Prize will recognize excellence in research aimed at curing intractable diseases and extending human life. The prize will be administered by the Breakthrough Prize in Life Sciences Foundation, a not-for-profit organization.

The first 11 recipients of the Breakthrough Prize are:

 

 

Just in

Biden signs TikTok ‘ban’ bill into law, starting the clock for ByteDance to divest it — The Verge

President Joe Biden signed a foreign aid package that includes a bill that would ban TikTok if China-based parent company ByteDance fails to divest the app within a year, writes Lauren Feiner.

IBM to acquire HashiCorp for $6.4B

IBM and HashiCorp have entered into an agreement for IBM to acquire HashiCorp, a provider of infrastructure and security management products, for $6.4 billion.

Oracle is moving its world headquarters to Nashville to be closer to health-care industry — CNBC

Oracle Chairman Larry Ellison said Tuesday that the company is moving its world headquarters to Nashville, Tennessee, to be closer to a major health-care epicenter, writes Ashley Capoot.